Bromfenac
Links shared publicly online about this topic
Mylan Pharmaceuticals launches bromfenac ophthalmic solution
osnsupersite.com — “PITTSBURGH --" Mylan Pharmaceuticals has launched bromfenac ophthalmic solution following a development and supply agreement with Coastal Pharm” View full resource at osnsupersite.com
Most Recently Shared on May 17, 2011 at 3:01 pm By:
#Mylan Pharmaceuticals launches #bromfenac #ophthalmic solution: http://ht.ly/4Ww9R
Yellox (bromfenac) eye drops launched | MIMS online
mims.co.uk — “The latest pharmaceutical, medical and drugs news on MIMS online” View full resource at mims.co.uk
Most Recently Shared on August 5, 2011 at 9:57 am By:
Yellox (bromfenac) eye drops launched: http://t.co/GaCwQjf
Bromday Eye Drops (Bromfenac Ophthalmic Solution) Approved For Post-operative Inflammation
medicalnewstoday.com — “Patients with post-operative eye inflammation as well as those who have undergone cataract surgery and experience eye pain may be considered for Bromday once-daily eye-drop treatment, as it was ap” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2010 at 1:05 am By:
Bromday Eye Drops (Bromfenac Ophthalmic Solution) Approved For Post-operative Inflammation http://mnt.to/3Lpp #healthnews
Ista Pharmaceuticals to discontinue twice-daily bromfenac in favor of once-daily formulation
osnsupersite.com — “IRVINE, Calif. — Ista Pharmaceuticals has announced plans to discontinue all shipments of twice-daily bromfenac ophthalmic solution 0.09% o” View full resource at osnsupersite.com
Most Recently Shared on February 8, 2011 at 4:12 pm By:
Ista Pharmaceuticals to discontinue twice-daily bromfenac in favor of once-daily formulation: http://ht.ly/3Sudg — #ophthalmology #business
Ista submits supplemental new drug application for once-daily bromfenac ophthalmic solution
osnsupersite.com — “IRVINE, Calif. " Ista Pharmaceuticals has submitted a supplemental new drug application to the U.S. Food and Drug Administration for a once-daily” View full resource at osnsupersite.com
Most Recently Shared on December 18, 2009 at 4:20 pm By:
Ista submits supplemental new drug application for once-daily bromfenac ophthalmic solution: http://ow.ly/Npw3 — #ophthalmology #business
Ista announces positive preliminary results from phase 3 trial of once-daily bromfenac
osnsupersite.com — “IRVINE, Calif. — Ista Pharmaceuticals has announced positive preliminary phase 3 results from the company's confirmatory clinical trial of a” View full resource at osnsupersite.com
Most Recently Shared on August 26, 2009 at 3:25 pm By:
Ista announces positive preliminary results from phase 3 trial of once-daily bromfenac: http://ow.ly/lplZ
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY™
medicalnewstoday.com — “ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application (sNDA) for BROMDAY™ (bromfenac” View full resource at medicalnewstoday.com
Most Recently Shared on October 19, 2010 at 1:05 pm By:
MNT Drug Approvals Health News
ISTA Pharmaceuticals Receives FDA Approval For BROMDAY™ http://mnt.to/3LpC #regulatory
ISTA Pharmaceuticals Receives FDA Approval for Bromday
drugs.com — “Bromday (bromfenac ophthalmic solution) is used to treat postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. Includes Bromday side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 12:10 am By:
Drugs and Devices OW OW Health
ISTA Pharmaceuticals Receives FDA Approval for Bromday: IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ -- IST... http://bit.ly/a2xJ9h #drug
ISTA Pharmaceuticals Receives FDA Approval for Bromday
drugs.com — “Bromday (bromfenac ophthalmic solution) is used to treat postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction. Includes Bromday side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 21, 2010 at 1:08 am By:
ISTA Pharmaceuticals Receives FDA Approval for Bromday - http://bit.ly/9KROwW
Clinical Trials Begin for Anti-inflammatory Product
hcplive.com — “An anti inflammatory product to reduce pain and inflammation associated with ocular surgery will undergo clinical trial.” View full resource at hcplive.com
Most Recently Shared on August 25, 2010 at 3:47 pm By:
Clinical Trials Begin for Anti-inflammatory Product http://hcp.lv/9DwF57
InSite Vision Commences Phase 1/2 Clinical Study Of ISV-303 For Post-Surgical Ocular Pain And Swelling
medicalnewstoday.com — “InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product” View full resource at medicalnewstoday.com
Most Recently Shared on August 25, 2010 at 1:00 pm By:
InSite Vision Commences Phase 1/2 Clinical Study Of ISV-303 For Post-Surgical Ocular Pain And Swelling http://mnt.to/3HNr #eyehealth
InSite Vision Files IND For ISV-101 With The U.S. Food And Drug Administration For The Treatment Of Dry Eye Disease
medicalnewstoday.com — “InSite Vision Incorporated (OTCBB:INSV) announced that it has filed an Investigational New Drug (IND) application for ISV-101 with the U.S. Food and Drug Administration (FDA). ISV-101 is InSite Vi” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2011 at 3:05 pm By:
InSite Vision Files IND For ISV-101 With The U.S. Food And Drug Administration For The Treatment Of Dry Eye Disease http://mnt.to/3PWD
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling
medicalnewstoday.com — “InSite Vision Incorporated (OTCBB:INSV), a company developing novel ophthalmic therapeutics, has announced that patient enrollment was recently completed in the company's Phase 1/2 clinical trial” View full resource at medicalnewstoday.com
Most Recently Shared on January 10, 2011 at 1:05 pm By:
InSite Vision Completes Patient Enrollment In ISV-303 Phase 1/2 Clinical Study For Post-Surgical Ocular Pain And Swelling http://mnt.to/3PMj
Phase 2 study of Remura for the treatment of dry eye disease - MPR
empr.com — “ISTA Pharmaceuticals announced the results from its Phase 2 trial of Remura (bromfenac ophthalmic solution) for the treatment of dry eye disease.” View full resource at empr.com
Most Recently Shared on September 28, 2010 at 8:14 pm By:
MPR News: Phase 2 study of Remura for the treatment of dry eye disease: ISTA Pharmaceuticals announced the results... http://bit.ly/cdMte8
Phase 2 study of Remura for the treatment of dry eye disease - ONA
oncologynurseadvisor.com — “ISTA Pharmaceuticals announced the results from its Phase 2 trial of Remura (bromfenac ophthalmic solution) for the treatment of dry eye disease.” View full resource at oncologynurseadvisor.com
Most Recently Shared on September 28, 2010 at 7:37 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
Phase 2 study of Remura for the treatment of dry eye disease http://goo.gl/fb/XzoD7
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
The OSN SuperSite
The Online home of Ocular Surgery News streamlined for the Web-savvy ophthalmic professional.
-
MIMS Online
MIMS is the print and online prescribing database for all healthcare professionals.
-
MNT Health News
Featured health news published by Medical News Today and chosen by the editorial team.
Advertisement
